## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the supplied abstract
- **Shared manuscript claim summary** The abstract reports a computational workflow for identifying hit-to-lead ligands targeting a G-quadruplex (G4) DNA structure in the c-Myc oncogene promoter, using BRACO-19 as a reference binder. The workflow involves high-throughput virtual screening (HTVS) of KEGG database entries, docking-based evaluation, selection by binding free energies and structural criteria, and analog design to propose a lead candidate.
- **Visible evidence base** Abstract text only; no figures, tables, methods details, or quantitative results are provided
- **Missing materials affecting confidence** Full manuscript, methods section, docking scores, structural criteria definitions, physicochemical data, pharmacological analysis, and any validation or comparison with experimental results

## Reviewer
- **Overall assessment** The abstract describes a plausible computational pipeline for G4-targeted ligand discovery, but the provided material is insufficient to evaluate the technical soundness, validity, or significance of the findings. The workflow is presented in a stepwise manner, yet key details such as docking software, scoring functions, structural criteria, and the basis for selecting the final lead are absent. The claim of a "lead candidate structure" is not supported by any structural or functional data in the abstract. The study may be of interest to computational medicinal chemists, but its contribution to the broader field cannot be assessed from the supplied text.
- **Who would be interested in the results, and why** Computational chemists and medicinal chemists working on G-quadruplex-targeting ligands or virtual screening methodologies may find the workflow relevant. Researchers focused on c-Myc oncogene regulation and cancer gene therapy could also be interested, provided the proposed lead is experimentally validated. However, the abstract alone does not demonstrate sufficient novelty or impact to attract a wide interdisciplinary audience.
- **Major strengths** The abstract clearly outlines a logical sequence of computational steps from database screening to lead proposal. The use of BRACO-19 as a reference binder with established thermodynamic and selectivity properties provides a reasonable starting point. The mention of physicochemical and pharmacological considerations in analog design suggests a degree of practical awareness.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract lacks any quantitative results, such as docking scores, binding free energy values, or structural descriptors. The criteria for selecting 22 hits from 95 and then 3 candidates from 22 are not specified. The "lead candidate structure" is mentioned but not described or validated. No comparison with known G4 binders or experimental data is provided. These omissions prevent any assessment of the reliability or significance of the proposed workflow.
- **Assessment against Nature-style criteria**  
  - Originality: The approach of using pharmacophore-based screening followed by docking is not novel in itself; the abstract does not demonstrate a unique methodological contribution.  
  - Scientific importance: The potential relevance to cancer therapy is acknowledged, but the abstract does not provide evidence that the proposed lead has any biological activity or advantage over existing compounds.  
  - Interdisciplinary readership: The topic bridges chemistry and biology, but the abstract is too technical and incomplete to engage a broad audience.  
  - Technical soundness: Cannot be evaluated due to missing methodological and quantitative details.  
  - Readability for nonspecialists: The abstract is concise but assumes familiarity with G4 structures, HTVS, and pharmacophore concepts; it is not accessible to a general scientific audience.
- **Recommendation posture** Currently not established from the provided evidence. The abstract outlines a workflow but does not provide sufficient data to support the claims of hit-to-lead identification or the proposal of a lead candidate. A full manuscript with detailed methods, results, and validation would be required for a supportive assessment.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The abstract claims that "95 hits are extracted and evaluated by docking them in the binding sites of G4" and that "22 hits are chosen by observing the binding free energies."  
- **Evidence pointer** Abstract text; location not provided  
- **Concern** The abstract does not specify the docking method, scoring function, or the definition of "binding free energies." No numerical values or statistical measures are given to support the selection of 22 hits from 95.  
- **Why it matters** Without these details, the reliability of the screening and selection steps cannot be assessed, and the results are not reproducible.  
- **Resolution test** Provide the docking software, scoring function, and a table or figure listing the binding free energies for all 95 hits, with clear criteria for the 22-hit selection.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Support for conclusions  
- **Claim pointer** The abstract states that "3 hit-to-lead candidates are selected on the basis of structural criteria" and that "a lead candidate structure is proposed."  
- **Evidence pointer** Abstract text; location not provided  
- **Concern** The structural criteria are not defined, and the proposed lead candidate is not described in any way, such as its chemical structure, properties, or predicted binding mode.  
- **Why it matters** The central conclusion of the study, the identification of a lead candidate, is unsupported by the abstract. Readers cannot evaluate the validity or utility of the proposed lead.  
- **Resolution test** Include the chemical structures of the 3 candidates and the lead, along with the structural criteria used for selection and a rationale for the final choice.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Validation and context  
- **Claim pointer** The abstract implies that the proposed lead has potential for experimental research, stating "Implications of the present study for experimental research are discussed."  
- **Evidence pointer** Abstract text; location not provided  
- **Concern** No experimental validation, comparison with known G4 binders, or assessment of drug-likeness is presented. The abstract does not indicate whether the proposed lead has been synthesized or tested.  
- **Why it matters** Computational predictions without experimental or comparative support are insufficient to establish the practical relevance of the proposed lead.  
- **Resolution test** Provide a comparison of the proposed lead with BRACO-19 and other known G4 ligands, including predicted or measured binding affinities, selectivity, and physicochemical properties.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Workflow description  
- **Evidence pointer** Abstract text  
- **Issue** The phrase "hit-to-lead ligands are identified" is ambiguous, as it is unclear whether the study identifies ligands that are already known or proposes new ones.  
- **Required correction** Clarify whether the identified ligands are novel or repurposed from the KEGG database.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Reproducibility  
- **Affected element** Database search  
- **Evidence pointer** Abstract text  
- **Issue** The abstract mentions "key pharmacophore features of BRACO-19" but does not describe these features or how they were derived.  
- **Required correction** Specify the pharmacophore features and the method used to define them.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Completeness  
- **Affected element** Lead candidate description  
- **Evidence pointer** Abstract text  
- **Issue** The abstract states that "analog design" was used but does not explain the design strategy or the physicochemical requirements considered.  
- **Required correction** Provide a brief description of the analog design approach and the specific physicochemical parameters used.

## Risk / unsupported claims
- The claim that 95 hits are "evaluated by docking" is unsupported without details on the docking protocol or results.
- The selection of 22 hits based on "binding free energies" is unsupported without numerical data.
- The selection of 3 candidates based on "structural criteria" is unsupported without defined criteria.
- The proposal of a "lead candidate structure" is unsupported without any structural or functional description.
- The implication that the lead has implications for experimental research is unsupported without validation or comparison data.